PRA International Expert to Speak at Late Phase Conference Breakout Session on Statistical Analysis

RALEIGH, N.C., Sept. 23 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that one of its Late Phase Services (LPS) experts will speak at the 13th Registries and Post-Approval Studies congress in Princeton, NJ 28-30 September 2010. PRA will also host a conference exhibit.

Kathleen Kushner, Director of Scientific Affairs for PRA's LPS group, will host the "Enhancing Statistical Analysis in Post-Approval Studies" breakout session. Ms. Kushner's session will discuss robust study design, collection techniques that promote quality data, and overcoming challenges associated with missing or inconsistent data. She will also address how innovative analysis can create value for multiple stakeholders.

PRA's exhibit will feature two of our LPS leaders, Hani Zaki, Senior Vice President, and Maria Harrison, Vice President. Additional PRA representatives will be available to discuss our successful late-phase programs.

Ms. Kushner's professional research career has focused primarily on post-approval development. Following her nursing training, she joined the pharmaceutical industry as a clinical data coordinator and transitioned to project management of late-phase projects. In these roles, she managed the data aspects of several large global post-approval projects from study design to analysis. She has been responsible for the overall management of late-phase studies, specializing in large national and international post-marketing and registry programs. As a Scientific Affairs director in PRA's LPS group, she consults with clients and project teams on all aspects of research from protocol development through statistical analysis.

PRA's LPS team supports global and regional post-approval studies utilizing an innovative integrated model combining its international Study Coordinating Center™ with leading technologies and management locations centralized in Horsham, Pennsylvania, and Mannheim, Germany.  PRA's highly experienced LPS team assists clients with the post-marketing process by planning and conducting longitudinal and retrospective studies, safety-surveillance studies, large simple trials, registries, and restricted access and risk management programs.  

For more information about the RPAS congress, navigate to www.praintl.com and click on "Events."

About PRA International

PRA International conducts clinical trials in more than 85 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. In the last five years, PRA has supported over 2,700 clinical trials through its 38 global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit www.PRAinternational.com, email [email protected] or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International